Back to results
US 11,959,918 B2Granted
Eukaryotic translation initiation factors (eIFs) as novel biomarkers in bladder cancer
AssigneeOtto-Von-Guericke-Universitat Magdeburg
InventorsJohannes Haybäck, Jeton Luzha
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of diagnosing bladder cancer in an individual. Further, the present invention relates to a method of determining the course of bladder cancer in an individual. Furthermore, the present invention relates to a kit for diagnosing bladder cancer in an individual or determining the course of bladder cancer in an individual.
Claims11
A method for treating bladder cancer, comprising the steps of:
- (i) providing a bladder tissue sample from an individual suspected of suffering from bladder cancer;
- (ii) determining the level of elF4B in the bladder tissue sample;
- (iii) diagnosing the individual as suffering from bladder cancer upon determining the level of elF4B higher than a reference level of elF4B from healthy individuals;
- and
- (iv) administering surgery, chemotherapy, radiotherapy, or immunotherapy to the individual to treat bladder cancer.
2 more elements
Dependencies are inferred from the claim text.